What's in Belén Retamal-Valdes's pipeline?

Belén Retamal-Valdes has 9 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 8 in Phase 1.

Which companies overlap with Belén Retamal-Valdes's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Bayer, Benova (Tianjin) Innovative medicine Research Co., Ltd., Centre Hospitalier Universitaire de Nice, Esraa Salah Mohamed Abdallah Eladl.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bel-n-retamal-valdes.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Belén Retamal-Valdes — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Belén Retamal-Valdes pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 8 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Metronidazole and Amoxicillin placebos	Metronidazole and Amoxicillin placebos	phase 3

Therapeutic area mix

Infectious Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Bayer · 1 shared drug class
Benova (Tianjin) Innovative medicine Research Co., Ltd. · 1 shared drug class
Centre Hospitalier Universitaire de Nice · 1 shared drug class
Esraa Salah Mohamed Abdallah Eladl · 1 shared drug class
Incheon St.Mary's Hospital · 1 shared drug class
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · 1 shared drug class
KEMRI-Wellcome Trust Collaborative Research Program · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Belén Retamal-Valdes:

Cite this brief

Drug Landscape (2026). Belén Retamal-Valdes — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bel-n-retamal-valdes. Accessed 2026-05-16.